학술논문

Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia.
Document Type
journal article
Source
Pediatric Blood & Cancer; Jul2021, Vol. 68 Issue 7, p1-8, 8p
Subject
Language
ISSN
15455009